Bone disease in organ transplant patients: pathogenesis and management

Bone disease is common in recipients of kidney, heart, lung, liver, and bone marrow transplants, and causes debilitating complications, such as osteoporosis, osteonecrosis, bone pain, and fractures. The frequency of fractures ranges from 6% to 45% for kidney transplant recipients to 22% to 42% for heart, lung, and liver transplant recipients. Bone disease in transplant patients is the sum of complex mechanisms that involve both preexisting bone disease before transplant and post-transplant bone loss due to the effects of immunosuppressive medications. Evaluation of bone disease should preferably start before the transplant or in the early post-transplant period and include assessment of bone mineral density and other metabolic factors that influence bone health. This requires close coordination between the primary care physician and transplant team. Patients should be stratified based on their fracture risk. Prevention and treatment include risk factor reduction, antiresorptive medications, such as bisphosphonates and calcitonin, calcitriol, and/or gonadal hormone replacement. A steroid-avoidance protocol may be considered.     

Relationships between exogenous-toxin quantity and increased biomass of transgenic Bt crops under elevated carbon dioxide

Field-OTC experiments were conducted with the goals of ascertaining if increased biomass in Bt transgenic cotton and rice grown under elevated CO₂ results in diminished exogenous-Bt toxin, and assessing the effectiveness of Bt transgenes against lepidopteran pests. Bt cotton responded differently, in terms of Bt-toxin quantity, than Bt rice, and both indicated differences among developmental stages. Dramatic biomass increase significantly diluted Bt-toxin content in 45-DAS (“days after seedling”) petioles and shoots and 90-DAS Bt cotton squares, and in the 50-DAS tissues and 100-DAS leaf sheaths of Bt rice. Moreover, the dilution effect was partially responsible for decreased Bt-toxin in these tissues, but not responsible for significant decreases in Bt-toxin in 90-DAS Bt cotton leaves and bolls. Furthermore, elevated CO₂ significantly affected the fitness and performance of Chilo suppressalis, and the susceptible and resistant colonies of Helicoverpa armigera, although adversely affected Bt-gene expression for the transgenic cotton and rice.     

Is vitamin D deficiency associated with heart failure? A review of current evidence

An estimated 1 billion people worldwide have deficient or insufficient levels of vitamin D. Even more alarming is the association of vitamin D deficiency with many types of diseases, particularly heart failure (HF). Hypovitaminosis D has been observed to be highly prevalent in the HF community with rates varying from approximately 80% to 95%. Higher rates of deficiency have been linked to winter months, in patients with protracted decompensated HF, darker skin pigmentation, and higher New York Heart Association (NYHA) classes. In fact, some data suggest vitamin D deficiency may even be an independent predictor of mortality in patients with HF. Traditionally obtained through UV exposure and activated in the liver and then the kidneys, vitamin D is classified as a vitamin but functions as a steroid hormone. The hormone acts through the vitamin D receptor (VDR), which is expressed in vascular smooth muscle cells, renal juxtaglomerular cells, and most interestingly, cardiac myocytes. Studies have shown that the association between vitamin D deficiency and HF often manifests in the structural components of cardiac myocytes and/or through alterations of the neurohormonal cascade. In addition, vitamin D may also act rapidly through intracellular nongenomic receptors that alter cardiac contractility. Unfortunately, prospective vitamin D supplementation trials show mixed results. In rat models, successful correction of deficiency was associated with reductions in ventricular hypertrophy. In humans, however, echocardiographic dimensions did not change significantly. These results bring into questions whether vitamin D is a risk factor for HF, a marker of HF disease severity, or has a true pathologic role. This article provides a thorough review of vitamin D deficiency etiology, prevalence, and possible pathophysiologic role in HF. Furthermore, we carefully review prospective trials on vitamin D therapy in HF. We believe more trials on vitamin D therapy in HF need to be conducted before any conclusions can be drawn.     

A comparison of circumumbilical and transverse abdominal incisions for neonatal abdominal surgery

Purpose

Although neonatal bowel surgery traditionally involves a transverse abdominal incision, several authors have reported that the circumumbilical incision is effective and cosmetically appealing. We report the first study comparing the circumumbilical incision to the transverse abdominal incision for a variety of neonatal abdominal operations.

Methods

Retrospective cohort analysis comparing the circumumbilical incision to the transverse abdominal incision for neonates who underwent surgical repair of malrotation, duodenal atresia/web, or intestinal atresia/web was performed between 1999 and 2009.

Results

One hundred thirty-two patients underwent a laparotomy through a transverse abdominal incision (n = 106) or a circumumbilical incision (n = 26). Baseline characteristics between groups were similar. No differences were found when comparing operative time, postoperative days on a ventilator, narcotic infusion, time to full feeds, length of hospital stay, incidence of surgical site infection, and bowel obstruction. Although more incisional hernias occurred in the circumumbilical incision group (38%) than the transverse abdominal incision group (6%), all hernias in the circumumbilical group resolved without intervention, whereas 33% required surgical repair in the transverse abdominal group.

Conclusions

Because of its cosmetic advantages and similar outcomes to the transverse abdominal incision, the circumumbilical incision should be considered as an alternative to the transverse abdominal approach in neonatal surgery.     

Study of Haralick’s and GLCM texture analysis on 3D medical images

Purpose of the study: Medical field has highly evolved with advancements in the technologies which prove to be beneficial for radiologists and patients for better diagnosis. The era of medical science provides best healthcare solutions with the help of medical images. Till now, 2D MRIs played a prominent role in early detection of disease but with latest technologies taking over the charge, 3D MRIs are highly effective and great in demand nowadays. With the aid of advanced techniques such as edge detection, segmentation and texture analysis on these images, the disease detection may become much easier.

Materials and Methods: Texture of any image is recognized by distribution of gray levels in the neighborhood. The Texture Analysis plays an important role in study of medical images. It identifies the prominent features of an image and highlights the same using different feature extraction technique. In this paper, 3D MRI of human brain is considered and texture analysis based on Haralick's and GLCM texture features is performed. Haralick's feature explains the image intensities of each pixel and their relationship with neighborhood pixels. The entire data set consists of 40 brain tumor patients, out of which a sample has been depicted.

Results: The analysis of different features such as Contrast, Correlation, Energy, Homogeneity and Entropy is carried out. Conclusion: Further, the study highlights about the highly useful features for early detection of brain tumor disease.     

Natural polyphenols based new therapeutic avenues for advanced biomedical applications

Polyphenols are naturally occurring, synthetic or semisynthetic organic compounds that offer a vast array of advanced biomedical applications. The mostly researched polyphenolic compounds are resveratrol and flavanols, notably (?)-epicatechin. The ongoing research on clinically important resveratrol and flavanols has revealed their potentials as extremely efficient drug agents that can be leveraged for new therapeutic designs for combating stroke related injuries, cancer and renal failures. Here, we have highlighted recent developments in this area with an emphasis on the biomedical applications of polyphenols. Also, a perspective on the future research directions has been discussed. We believe that this review would facilitate further research and development of polyphenols as a therapeutic avenue in medical science.     

Tyrosine Kinase Inhibitor-Induced Hypertension

Purpose of Review

The purpose of this paper is to identify commonly used tyrosine kinase inhibitors (TKIs) that are associated with hypertension, primarily, vascular endothelial growth factor (VEGF) signaling pathway (VSP) inhibitors. We review the incidence, mechanism, and strategies for management of TKI-induced HTN. We hope to provide clinicians with guidance on how to manage similar clinical scenarios.

Recent Findings

Many of the newer VSP inhibitors are reviewed here, including cediranib, axitinib, pazopanib, and ponatinib. Trials utilizing prophylactic treatment with angiotensin system inhibitors (ASIs) are discussed as well as recent data showing an improvement in overall survival and progression-free survival in patients on ASIs and TKI-induced hypertension.

Summary

The incidence of TKI-induced HTN among the VEGF inhibitors ranges from 5 to 80% and is dose dependent. Newer generation small-molecule TKIs has a lower incidence. The mechanism of action involves VSP inhibition, leading to decreased nitric oxide and increased endothelin production, which causes vasoconstriction, capillary rarefaction, and hypertension. ASIs and calcium channel blockers are first-line therapy for treatment and are associated with improved overall survival. Nitrates and beta-blockers are associated with in vitro cancer regression; however, there is a paucity of trials regarding their use as an anti-hypertensive agent in the TKI-induced HTN patient population.